WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
Soft tissue sarcomas (STS) are a very heterogeneous group of rare tumors, comprising more than 50 different histological subtypes that originate from mesenchymal tissue. Despite their heterogeneity, chemotherapy based on doxorubicin (DXR) has been in use for forty years now and remains the standard...
Enregistré dans:
Auteurs principaux: | Esther Martinez-Font, Marina Pérez-Capó, Oliver Vögler, Javier Martín-Broto, Regina Alemany, Antònia Obrador-Hevia |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a45dc9a8d91e4650bb49e2236ccc4c4f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
par: A. S. Kulakova, et autres
Publié: (2021) -
FERMT3 mediates cigarette smoke-induced epithelial–mesenchymal transition through Wnt/β-catenin signaling
par: Xiaoshan Su, et autres
Publié: (2021) -
CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway
par: Li-Na Gao, et autres
Publié: (2021) -
Wnt/β-Catenin Pathway in Experimental Model of Fibromyalgia: Role of Hidrox<sup>®</sup>
par: Ramona D’Amico, et autres
Publié: (2021) -
Expression of Wnt and β-Catenin in Mouse Tooth Germs and Chick Facial Primordia: A Comparison
par: Louryan,S., et autres
Publié: (2018)